Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.45 |
| ▸ | HTR6 | P50406 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | BRPF1 | P55201 | 2/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.39 |
| ▸ | PRKCG | P05129 | 1/20 | 0.39 |
| ▸ | PRKCB | P05771 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.39 |
| ▸ | PRKCH | P24723 | 1/20 | 0.39 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.39 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.39 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.39 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL5996484 | 0.99 | MYC (0.44) | MYCHTR6ALDH1A1LMNABRPF1 | |
| SCHEMBL20129650 | 0.86 | CA2 (0.43) | HTR6ALDH1A1LMNABRPF1BRD4 | |
| SCHEMBL6849293 | 0.84 | HTR6 (0.43) | MYCHTR6ALDH1A1LMNADRD2 | |
| SCHEMBL6288232 | 0.84 | HTR6 (0.43) | MYCHTR6DRD2 | |
| SCHEMBL6847420 | 0.84 | HDAC1 (0.41) | MYCHTR6ALDH1A1LMNAPRKCQ | |
| SCHEMBL6849062 | 0.82 | RPS6KB1 (0.47) | MYCHTR6PRKCQPRKCD | |
| SCHEMBL2851145 | 0.82 | ADRB1 (0.41) | MYCHTR6BIRC2DRD2 | |
| SCHEMBL6848056 | 0.81 | LATS1 (0.40) | MYCHTR6PRKCQHTR2CDRD2 | |
| SCHEMBL6847591 | 0.79 | HTR6 (0.39) | MYCHTR6CYP3A4HRH4 | |
| SCHEMBL8632814 | 0.79 | HTR6 (0.67) | MYCHTR6ALDH1A1LMNACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7652017-B2 | Remedies and/or preventives for nervous system disorders | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-01-26 | — | — | US | claimed |
| CN-100502861-C | Medicament inhibiting sodium/calcium exchange system | MITSUBISHI PHARMA CORP (JP) | 2009-06-24 | — | — | CN | claimed |
| CN-100496495-C | Remedies and/or preventives for diabetic ischemic heart diseases | MITSUBISHI PHARMA CORP (JP) | 2009-06-10 | — | — | CN | claimed |
| CN-100486574-C | Remedies and/or preventives for nervous system disorders | MITSUBISHI PHARMACEUTICALS INC (JP) | 2009-05-13 | — | — | CN | claimed |
| CN-1946396-A | Medicine for prevention and/or treatment of ischemic circulatory disease | MITSUBISHI PHARMA CORP (JP) | 2007-04-11 | — | — | CN | claimed |
| CN-1638773-A | Pharmaceutical preparation containing aminobenzenesulfonic acid derivative as active ingredient | MITSUBISHI PHARMA CORP (JP) | 2005-07-13 | — | — | CN | claimed |
| CN-1533292-A | Medicament inhititing sodium/calcium exchange system | 三菱制药株式会社 | 2004-09-29 | — | — | CN | claimed |
| CN-1496261-A | Remedies and/or preventives for diabetic ischemic heart diseases | 三菱制药株式会社 | 2004-05-12 | — | — | CN | claimed |
| EP-1374868-A1 | REMEDIES AND/OR PREVENTIVES FOR DIABETIC ISCHEMIC HEART DISEASES | Mitsubishi Pharma Corporation (JP) | 2004-01-02 | — | — | EP | claimed |
| CN-1434724-A | Remedies and/or preventives for nervous system disorders | MITSUBISHI PHARMACEUTICALS INC (JP) | 2003-08-06 | — | — | CN | claimed |
| WO-2026004998-A1 | PHARMACEUTICAL COMPOSITION FOR KERATOSIS AND USE THEREOF | 田辺三菱製薬株式会社 | 2026-01-02 | — | — | WO | disclosed |
| CN-100502861-C | Medicament inhibiting sodium/calcium exchange system | MITSUBISHI PHARMA CORP (JP) | 2009-06-24 | — | — | CN | disclosed |
| CN-100496495-C | Remedies and/or preventives for diabetic ischemic heart diseases | MITSUBISHI PHARMA CORP (JP) | 2009-06-10 | — | — | CN | disclosed |
| CN-100486574-C | Remedies and/or preventives for nervous system disorders | MITSUBISHI PHARMACEUTICALS INC (JP) | 2009-05-13 | — | — | CN | disclosed |
| CN-1946396-A | Medicine for prevention and/or treatment of ischemic circulatory disease | MITSUBISHI PHARMA CORP (JP) | 2007-04-11 | — | — | CN | disclosed |
| CN-1434724-A | Remedies and/or preventives for nervous system disorders | MITSUBISHI PHARMACEUTICALS INC (JP) | 2003-08-06 | — | — | CN | disclosed |
| US-6245767-B1 | CARDIOVASCUALR DISORDERS | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-06-12 | — | — | US | disclosed |
| EP-0779283-B1 | Monohydrates of aminobenzenesulfonic acid derivatives and method for preparation thereof | MITSUBISHI CHEM CORP (JP) | 2000-03-01 | — | — | EP | disclosed |
| US-5990113-A | MONOHYDRATE OF 2-(1-PIPERAZINYL)-5-METHYLBENZENESULFONIC ACID, FREE OF ANHYDROUS CRYSTALS; FREE FROM WEIGHT CHANGE DUE TO MOISTURE ABSORPTION AND CAN BE WEIGHED ACCURATELY IN MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR HEART DISEASES | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-11-23 | — | — | US | disclosed |
| EP-0779283-A1 | Monohydrates of aminobenzenesulfonic acid derivatives and method for preparation thereof | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-06-18 | — | — | EP | disclosed |